Hims and Hers Health to Acquire Eucalyptus in Billion Dollar Expansion Deal
The telehealth giant will expand into Australia and Japan through the acquisition of Eucalyptus. This deal aims to bolster its global personalized care reach.
Insights:
Hims & Hers Health, Inc. announced on February 19, 2026, that it has entered into a definitive agreement to acquire Eucalyptus, a prominent digital health company based in Australia 
AU, for a total transaction value of up to $1.15 billion. The acquisition is intended to provide an immediate expansion of the company's international footprint and scale its personalized care business into new global markets. The deal is currently in the announced phase and is expected to close in mid-2026.
AU, for a total transaction value of up to $1.15 billion. The acquisition is intended to provide an immediate expansion of the company's international footprint and scale its personalized care business into new global markets. The deal is currently in the announced phase and is expected to close in mid-2026.Financial terms of the agreement specify that the transaction includes $240 million payable in cash upon the closing of the deal. This strategic move establishes an immediate presence for the United States 
US based telehealth platform in Japan 
JP and the Australian market. Furthermore, the acquisition is set to deepen existing partnerships and operations in the United Kingdom 
GB, Germany 
DE, and Canada 
CA.
US based telehealth platform in Japan JP and the Australian market. Furthermore, the acquisition is set to deepen existing partnerships and operations in the United Kingdom GB, Germany DE, and Canada CA.
